FEASIBILITY STUDY OF INDIA'S STAND ON COMPULSORY LICENSING OF COVID VACCINES UNDER WTO TRIPS REGIME

Abstract

On “March 30, 2021”, many national leaders and humanitarian bodies issued an exceptional unified demand for a new interim agreement on global preventing and responding, stating that there would be more outbreaks and catastrophic medical catastrophes. This danger cannot be addressed by a specific nation or intergovernmental organisation. The issue isn't if it will happen, but how and at what time will it take place. 

As the globe grapples with said “coronavirus (COVID-19)” epidemic, the appeal represents the depressing reality of the issues that this outbreak has presented to us, as well as the incapacity of the existing framework to solve them. Although various drug manufacturers have managed to conquer the initial tremendous obstacle of producing a vaccine notwithstanding this coronavirus, and a variety of medicines are already in the process. The next, but another primarily important, challenge is to make the requisite amount of vaccinations and disseminate them evenly and economically over the world. Sometimes this obstacle, on the other hand, has been believed to be a major problem. To protect over 80% of the global total, roughly 15 billion shots are predicted to be necessary. Upwards of 2 billion vaccine units have indeed been delivered worldwide, as per the World Health Organization (WHO), with much more than 80% among those shots given in high- and topmost nations but merely 0.3 percentage in least developed states. It's been suggested that getting individuals at lower earning communities immunised might take decades. As a result, this issue has presented an important topic i.e. In what way can the nations increase the speed with which vaccinations are produced and distributed globally at a reasonable cost?